{"id":"W2060221163","doi":"10.1007/s12325-012-0037-5","title":"Treatment Patterns in the First Year After Initiating Tumor Necrosis Factor Blockers in Real-World Settings","year":2012,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thomson Reuters (Canada)","funders":"Pfizer; Amgen","keywords":"Etanercept; Medicine; Adalimumab; Infliximab; Golimumab; Psoriatic arthritis; Rheumatoid arthritis; Internal medicine; Abatacept; Ankylosing spondylitis; Psoriasis; Ustekinumab; Tumor necrosis factor alpha; Rituximab; Dermatology; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000230273,0.000170294,0.0002653942,0.0002117025,0.00004400556,0.00002679992,0.0001118001,0.0000293684,0.0002316783],"category_scores_gemma":[0.00002929506,0.0001095795,0.00005910083,0.0003160397,0.00006471966,0.0003537507,0.00001556288,0.0002067292,0.00001768074],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000159023,"about_ca_system_score_gemma":0.00002743167,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000874584,"about_ca_topic_score_gemma":0.007438533,"domain_scores_codex":[0.9986722,0.0001026996,0.0002858098,0.0001882333,0.0002330291,0.0005180594],"domain_scores_gemma":[0.9993983,0.0002327301,0.00005773037,0.0002309816,0.000014544,0.00006574135],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003416298,0.0002954624,0.9522063,0.0000137029,0.0000138615,0.00005142197,0.01050264,0.000001624536,0.00006656018,0.00005044512,0.00001318404,0.03644318],"study_design_scores_gemma":[0.004604715,0.0004004809,0.933554,0.0004042893,8.87338e-7,0.00001232137,0.00235048,0.00002070457,0.001232454,0.0002066279,0.05704653,0.0001665076],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875013,0.009549421,0.000001988211,0.001643195,0.00007407434,0.0005513643,0.00001611277,0.00001992735,0.0006426668],"genre_scores_gemma":[0.9220225,0.07659286,0.0002206374,0.0006713623,0.00007931339,0.0003560231,0.000007981746,0.00002205028,0.00002729238],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06704343,"threshold_uncertainty_score":0.4468523,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02027643044986484,"score_gpt":0.3219488934943859,"score_spread":0.3016724630445211,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}